Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,170.00
Bid: 12,172.00
Ask: 12,174.00
Change: 108.00 (0.90%)
Spread: 2.00 (0.016%)
Open: 12,194.00
High: 12,266.00
Low: 12,054.00
Prev. Close: 12,062.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET COMMENT: FTSE 100 Slides On US Jobs Data, Miners Weigh

Fri, 06th Mar 2015 16:51

LONDON (Alliance News) - The FTSE 100 ended lower Friday, and ended down over the week as a whole, as London-listed mining stocks were again hit by lower commodity prices, and as stocks in the US were hit by a by a better-than-expected US jobs report that raised expectations the Federal Reserve could start raising interest rates as soon as June.

The FTSE 100 was lower from the start as mining stocks came under pressure from lower commodity prices. The index has a large number of constituents in the sector. It dropped further once the US jobs data was released.

The blue-chip index closed down 0.7% at 6,911.80, meaning it was down 0.5% for the week as a whole. The FTSE 250 closed down 0.2% at 17,272.21, while the AIM All-Share index outperformed, closing up 0.6% at 718.11.

The US Labor Department said non-farm payroll employment jumped by 295,000 jobs in February, following a downwardly revised increase of 239,000 jobs in January. Economists had expected employment to increase by about 230,000 jobs compared with the addition of 257,000 jobs originally reported for the previous month.

The US unemployment rate fell to 5.5% in February, from 5.7% in January, coming in below economists' estimates for a rate of 5.6% and recording its lowest level since hitting 5.4% in May of 2008.

"I think this is a very good labour market report and will only feed into expectations for a rate hike from the Federal Reserve in June," said Oanda analyst Craig Erlam.

But Erlam thinks the June meeting may just come a little soon, with wage growth not quite taking off yet. "I still believe that the Fed will wait until September to act. They are clearly in no rush to make this decision and with inflation below target, they don’t need to," he said.

The dollar strengthened further against its major counterparts in the wake of the report, trading the pound at USD1.5081 while the euro was at its lowest level since September 2003 at USD1.0876.

The gold price fell due to the dollar's rise, and was quoted at USD1,174.02 when the London equity markets closed, its lowest level since early January.

When the London equity markets closed, Wall Street was lower, with the DJIA down 1.0%, the S&P 500 down 0.8% and the Nasdaq Composite down 0.6%. Tech giant Apple will replace AT&T in the DJIA on March 18.

In Europe, the CAC 40 in Paris closed up 0.1%, and the DAX 30 in Frankfurt ended up 0.4%.

Fourth quarter eurozone GDP met expectations, rising 0.9% quarter-on-quarter. The figure was a slight improvement on the third quarter reading of 0.8%. The year-on-year figure also matched estimates of 0.3% growth, marginally higher than the 0.2% shown in the third quarter.

The median expectations for UK inflation for the coming year was 1.9% in February compared with 2.5% in November, according to a survey from the Bank of England. This was its lowest level in more than 13 years. UK inflation had fallen to a record low 0.3% in January, dragged by falling motor fuel and food prices.

In London, gold miners suffered from the weakness of the precious metal price, with Randgold Resources ending as the worst performer in the FTSE 100, down 5.3%, followed by Fresnillo, down 5.2%.

Anglo American was down 2.5% while Rio Tinto slid 2.3% as iron ore prices fell to a fresh six-year low, according to reports.

Outside of mining, AstraZeneca closed down 1.6%. The pharmaceutical giant guided that it expects its total revenue to decline by a mid-single digit percentage at constant exchange rates in 2015, in line with previous sales revenue guidance it gave at the time of its full-year results, as it announced changes to the way it presents its revenue. AstraZeneca maintained its core earnings per share guidance.

Oil and gas service company Weir Group was the biggest gainer in the blue-chip index, up 4.3% at 1,827 pence, as several media reported speculation that it could attract a bid from a US private equity firm. The Independent said that GE Capital is being linked with making a 2,800.00 pence per share bid, though it attributed this to "starry-eyed punters".

Shares in FTSE 250-listed Thomas Cook Group flew up 25%, after Chinese investment firm Fosun International bought a 5% stake in the UK travel operator and said it plans to increase its stake to 10% by buying shares in the open market over time.

Under the deal, Thomas Cook will issue Fosun with 73.1 million new shares for GBP91.8 million, giving it a 5% stake in the business. Fosun will then buy shares in the open market to take its stake up to about 10% over time. The share issue values Thomas Cook shares at 125.58 pence.

In the corporate calendar Monday, WPP, Clarkson, HgCapital Trust, Hansteen Holdings and Mincon Group will issue full year results, while Gemfields and Abcam will release half year results.

In the economic calendar, German current account and import and export data are due at 0700 GMT. Eurozone sentix investor confidence is at 0930 GMT followed by the Eurogroup meeting in Brussels at 1530 GMT. In the US, Labor market conditions index is at 1400 GMT.

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more
4 Apr 2024 13:09

UK shareholder meetings calendar - next 7 days

Friday 5 April 
Faron Pharmaceuticals LtdAGM
VPC Specialty Lending Investments PLCGM re capital return via B share scheme
Monday 8 April 
Premier African Minerals LtdAGM
Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
Wednesday 10 April 
Valereum PLCAGM
Wincanton PLCGM re takeover by GXO Logistics Inc
Thursday 11 April 
AstraZeneca PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 17:22

UK's FTSE 100 pressured by stronger pound; miners climb

FTSE 100 flat, FTSE 250 up 0.2%

*

Read more
3 Apr 2024 11:02

CORRECT: AstraZeneca, Daiichi make US progress with licence approvals

(Correcting the description of extravascular haemolysis' effects on patients with paroxysmal nocturnal haemoglobinuria)

Read more
2 Apr 2024 15:22

London close: Stocks turn red on return from Easter break

(Sharecast News) - UK stocks experienced a downturn by the end of trading on Tuesday, as investors resumed activity following the extended weekend, with initial gains reversed by the close ahead of a week marked by a number of key economic data releases.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.